• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AESCULAP AG VEGA SYSTEM® PS+; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AESCULAP AG VEGA SYSTEM® PS+; PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL Back to Search Results
Model Number NX220
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Failure of Implant (1924)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The adverse event is filed under ais reference: (b)(4).Investigation on-going.Should relevant additional information / investigation results become available, a supplemental medwatch report will be submitted.
 
Event or Problem Description
An outside law firm reported that a patient experienced complications following a left knee prosthesis that required subsequent medical intervention.According to the operative report dated (b)(6) 2022, the patient underwent a left total knee arthroplasty (tka) for osteoarthritis.The procedure was performed using cemented knee components (aesculap system) with palacos bone cement.The operative report indicates the patient tolerated the procedure well with no intraoperative complications, and the implants were placed with appropriate alignment and stability.Following the procedure, the patient developed persistent stiffness, pain, and reduced range of motion.On (b)(6) 2022, the patient underwent manipulation under anesthesia, joint aspiration, and femoral nerve injection due to continued stiffness.Symptoms persisted despite intervention.According to a subsequent operative report dated (b)(6) 2023, the patient underwent a revision procedure with tibial component revision and posterior capsular release due to arthrofibrosis and stiffness.According to a later operative report dated (b)(6) 2024, the patient underwent a revision left total knee arthroplasty due to aseptic loosening of the femoral and tibial components.Intraoperatively, both components were noted to be grossly loose, with no cement adherent to the implants.The components were removed without significant bone loss.Revision was performed using stemmed femoral and tibial components and bone cement.Final implantation demonstrated stable fixation with appropriate alignment and full range of motion without instability.The patient tolerated the procedure and was transferred to recovery in stable condition with no intraoperative complications reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VEGA SYSTEM® PS+
Common Device Name
PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL
Manufacturer (Section D)
AESCULAP AG
po box 40
tuttlingen, 78501
GM  78501
MDR Report Key24687121
Report Number3005673311-2026-00038
Device Sequence Number15884441
Product Code JWH
UDI-Device Identifier04046963811181
UDI-Public(01)04046963811181(11)220623(17)270622(10)52770790
Combination Product (Y/N)N
Initial Reporter StateGA
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)Unknown
Reporter Type Importer
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/25/2026
Report Date (Section F) 03/25/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberNX220
Device Catalogue NumberNX220
Device Lot Number52770790
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Distributor Facility Aware Date03/03/2026
Device Age30 MO
Event Location Hospital
Date Report to Manufacturer03/03/2026
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date03/25/2026
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
Date Report Sent to FDA03/25/2026
-
-